These tablets are available in strengths of 25 mg, 50 mg, 100 mg, and 200 mg, and they are intended to serve as a generic version of Toprol-XL® Tablets by Sequel Therapeutics, LLC. The manufacturing ...

1 st and only once-daily combination containing the active ingredient of TOPROL-XL ® (metoprolol succinate) ER tablets plus low-dose hydrochlorothiazide, offers the dual efficacy of a beta blocker and ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Granules India has received approval from the US Food & Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Metoprolol Succinate ER Tablets in varying strengths: 25mg, ...

Metoprolol tartrate and metoprolol succinate are different salt forms of the same active ingredient, metoprolol. Although they are similar, they have different uses and effects. Metoprolol belongs to ...

Global pharma major Lupin Limited (Lupin) on Wednesday announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application ...

The FDA has announced a nationwide recall of over 13,000 bottles of Dr. Reddy’s Laboratories‘ Metoprolol Succinate Extended-Release Tablets, the generic version of AstraZeneca’s Toprol XL. The recall ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. For the above reasons, Medindia cannot be held ...

Previous studies showed that treatment with beta-blockers improves LV remodeling and clinical outcomes in patients with symptomatic heart failure due to systolic LV dysfunction, but to date there has ...

Share price of Cipla rose 1.6 percent intraday Monday as company received final approval from USFDA. The company has received final approval for its abbreviated new drug application (ANDA) for ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced the availability of DUTOPROL™ (metoprolol succinate extended release/hydrochlorothiazide) Tablets, the first and only ...